Table I Index
Table of Contents
|
Table I - 64 Porter Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 516 | 351.4 | 265 | 414.6 | 251 | 309.3 |
| Oral cavity and pharynx | 15 | 10.2** | 10 | 14.0** | 5 | 6.4** |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 97 | 64.6 | 53 | 82.6 | 44 | 49.8 |
| Esophagus | 7 | 4.5** | 5 | 8.2** | * | # |
| Stomach | 8 | 5.3** | 5 | 7.1** | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 52 | 34.5 | 27 | 43.7 | 25 | 28.5 |
| Rectum and rectosigmoid | 14 | 9.8** | 10 | 15.7** | * | # |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 10 | 6.7** | * | # | 6 | 6.5** |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 81 | 56.4 | 44 | 66.5 | 37 | 48.0 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 7 | 5.5** | 7 | 11.1** | * | # |
| Lung and bronchus | 71 | 48.9 | 34 | 50.5 | 37 | 48.0 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 18 | 11.0** | 11 | 14.5** | 7 | 8.4** |
| Melanoma of the skin | 16 | 10.0** | 9 | 12.2** | 7 | 8.4** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 78 | 52.1 | * | # | 78 | 98.6 |
| Female genital system | 28 | 17.8 | -- | -- | 28 | 33.8 |
| Cervix uteri | 5 | 2.5** | -- | -- | 5 | 5.0** |
| Corpus uteri | 9 | 5.9** | -- | -- | 9 | 10.7** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 12 | 8.2** | -- | -- | 12 | 15.6** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 79 | 55.2 | 79 | 129.4 | -- | -- |
| Prostate gland | 77 | 53.8 | 77 | 126.6 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 42 | 28.7 | 25 | 40.4 | 17 | 19.7** |
| Urinary bladder | 25 | 17.4 | 17 | 28.1** | 8 | 9.2** |
| Kidney and renal pelvis | 17 | 11.3** | 8 | 12.4** | 9 | 10.5** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 13 | 9.3** | 7 | 10.3** | 6 | 8.0** |
| Brain | 13 | 9.3** | 7 | 10.3** | 6 | 8.0** |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 26 | 18.4 | 15 | 23.1** | 11 | 14.2** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 25 | 17.7 | 14 | 21.6** | 11 | 14.2** |
| Multiple myeloma | 6 | 4.4** | * | # | * | # |
| Leukemia | 12 | 9.4** | 9 | 15.3** | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | 5 | 3.8** | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 10 | 6.5** | 6 | 8.6** | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||